These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25644318)

  • 1. Cryptococcosis in HIV-infected hospitalized patients in Germany: Evidence for routine antigen testing.
    Katchanov J; Jefferys L; Tominski D; Wöstmann K; Slevogt H; Arastéh K; Stocker H
    J Infect; 2015 Jul; 71(1):110-6. PubMed ID: 25644318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia.
    Escandón P; Lizarazo J; Agudelo CI; Chiller T; Castañeda E
    Med Mycol; 2013 Oct; 51(7):765-8. PubMed ID: 23611420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
    Karaman E; Ilkit M; Kuşçu F
    Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.
    Kadam D; Chandanwale A; Bharadwaj R; Nevrekar N; Joshi S; Patil S; Gupte N; Sangle S; Chopade K; Kulkarni V; Balasubramanian U; Suryavanshi N; Jain D; Kanade S; Dharmashale S; Kagal A; Gupta A; Mave V
    Indian J Med Microbiol; 2017; 35(1):105-108. PubMed ID: 28303828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
    Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
    HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
    Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
    Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
    Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
    Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
    McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
    Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
    Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
    Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.
    Sawadogo S; Makumbi B; Purfield A; Ndjavera C; Mutandi G; Maher A; Kaindjee-Tjituka F; Kaplan JE; Park BJ; Lowrance DW
    PLoS One; 2016; 11(10):e0161830. PubMed ID: 27760140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
    Pongsai P; Atamasirikul K; Sungkanuparph S
    J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
    Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
    Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
    Cassim N; Schnippel K; Coetzee LM; Glencross DK
    PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis.
    Rajasingham R; Govender NP; Jordan A; Loyse A; Shroufi A; Denning DW; Meya DB; Chiller TM; Boulware DR
    Lancet Infect Dis; 2022 Dec; 22(12):1748-1755. PubMed ID: 36049486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
    Osazuwa OF; Dirisu O; Okuonghae E
    Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.